Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.62 SEK
−21.09 M SEK
0.00 SEK
44.75 M
About MOBERG PHARMA AB
Sector
CEO
Anna Ljung
Headquarters
Bromma
Website
Founded
2006
ISIN
SE0020353928
FIGI
BBG00191NX89
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MOB is 18.71 SEK — it has increased by 2.42% in the past 24 hours. Watch MOBERG PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MOBERG PHARMA AB stocks are traded under the ticker MOB.
MOB stock has risen by 13.94% compared to the previous week, the month change is a 57.84% rise, over the last year MOBERG PHARMA AB has showed a 107.89% increase.
We've gathered analysts' opinions on MOBERG PHARMA AB future price: according to them, MOB price has a max estimate of 19.00 SEK and a min estimate of 19.00 SEK. Watch MOB chart and read a more detailed MOBERG PHARMA AB stock forecast: see what analysts think of MOBERG PHARMA AB and suggest that you do with its stocks.
MOB stock is 7.44% volatile and has beta coefficient of 0.29. Track MOBERG PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is MOBERG PHARMA AB there?
Today MOBERG PHARMA AB has the market capitalization of 831.14 M, it has increased by 19.54% over the last week.
Yes, you can track MOBERG PHARMA AB financials in yearly and quarterly reports right on TradingView.
MOBERG PHARMA AB is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
MOB earnings for the last quarter are −0.10 SEK per share, whereas the estimation was −0.10 SEK resulting in a −0.16% surprise. The estimated earnings for the next quarter are −0.12 SEK per share. See more details about MOBERG PHARMA AB earnings.
MOBERG PHARMA AB revenue for the last quarter amounts to 3.80 M SEK, despite the estimated figure of 3.50 M SEK. In the next quarter, revenue is expected to reach 600.00 K SEK.
MOB net income for the last quarter is −1.26 M SEK, while the quarter before that showed −4.05 M SEK of net income which accounts for 68.83% change. Track more MOBERG PHARMA AB financial stats to get the full picture.
No, MOB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 10.00 employees. See our rating of the largest employees — is MOBERG PHARMA AB on this list?
Like other stocks, MOB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOBERG PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOBERG PHARMA AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOBERG PHARMA AB stock shows the sell signal. See more of MOBERG PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.